Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Microplastic and male urogenital health: current evidence and clinical implications].

Created on 15 Sep 2026

Authors

T Klotz

Published in

Urologie (Heidelberg, Germany). Sep 14, 2026. Epub Sep 14, 2026.

Abstract

Microplastic particles (MPs; <5 mm) are ubiquitous environmental contaminants now detected in human tissues, including testicular tissue, semen, and prostate.
This narrative review synthesizes current evidence on MPs and male urogenital health and derives precautionary counselling points for urologists.
Narrative review with a structured PubMed/MEDLINE search using three thematic blocks (andrology and fertility, uro-oncology, urinary tract, and exposure) covering 1/2020 to 8/2026, supplemented by reference-list hand searching and regulatory primary documents. Human studies as well as animal and in vitro models with urologically relevant endpoints were included. No formal risk-of-bias assessment was performed.
MPs have been detected in human testicular tissue, semen, and prostate tissue. Animal and in vitro work describes impaired spermatogenesis, oxidative stress in Leydig cells, and testosterone suppression. Transferability to human exposure conditions is not established. The available human data derive exclusively from small cross-sectional studies and show polymer-specific, mutually inconsistent associations with semen parameters. Prostate tumor tissue showed higher MP concentrations than adjacent reference tissue. In vitro data suggest pro-proliferative effects. For bladder cancer, cytotoxic in vitro data and one ecological correlation analysis are available.
MPs are regularly detectable in the male urogenital tract. A causal link with impaired fertility or urological carcinogenesis has not been established in humans. The evidence is of low to very low quality. It justifies clinical vigilance, extended environmental history-taking, and precautionary, low-risk counselling, but no change to guideline-based diagnostic or therapeutic algorithms.

PMID:
42734812
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement